u/GorditoChiquitito · 254d agono track record yet
SELLAS Life Sciences (SLS) - Deep Dive DD on GPS and the REGAL trial
Author has conducted comprehensive research on SLS's GPS and REGAL trial catalysts and believes the opportunity merits investment. The detailed DD article serves as a resource for evaluating the company's potential.
At post $3.81Now $10.72+181.4% since postedas of Oct 19, 11:31 AM ET
1d—
3d-1.3%
1w-5.8%
1m+56.4%
3m+31.5%
6m+207.1%
1y—